EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study

J S K Chan, Y H A Lee, J M H Hui, K Liu, E C Dee, K Ng, P Tang, G Tse, C F Ng

Clinical Oncology · 2023

DOI: 10.1016/j.clon.2023.03.014 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Oncology, 2023. Verfasst von J S K Chan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Myocardial Infarction, Prostatic Neoplasms, Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Hong Kong Metropolitan University, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Gonadotropin-releasing hormone (GnRH) agonists and antagonists, critical medications for prostate cancer (PCa) treatment, may differ in cardiovascular safety. This prospective cohort study aimed to compare the long-term cardiovascular risks between GnRH agonists and antagonists. MATERIALS AND METHODS: Patients with PCa receiving GnRH agonists or antagonists during 2013-2021 in Hong Kong were identified. Patients with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMyocardial InfarctionProstatic NeoplasmsStrokeMaleHumansAgedAged, 80 and overGonadotropin-Releasing HormoneRisk FactorsProspective StudiesCohort StudiesAndrogen AntagonistsHeart Disease Risk Factors

Stichwörter der Autor:innen

Androgen deprivation therapyMACEcardio-oncologycohorthormonal therapyprostate cancer

Substanzen

Gonadotropin-Releasing HormoneAndrogen Antagonists

Autor:innen und Institutionen

  • Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
  • Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, C…
  • Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Cardio-oncology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China; Kent and Medway Medical School, Canterbury, UK; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascul…

Förderung

  • Hong Kong Metropolitan University
  • National Cancer Institute

Zitieren

APA

Chan, J. S. K., Lee, Y. H. A., Hui, J. M. H., Liu, K., Dee, E. C., Ng, K., Tang, P., Tse, G., & Ng, C. F. (2023). Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study. Clinical Oncology. https://doi.org/10.1016/j.clon.2023.03.014

Vancouver

Chan JSK, Lee YHA, Hui JMH, Liu K, Dee EC, Ng K, et al. Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study. Clinical Oncology. 2023. doi:10.1016/j.clon.2023.03.014

BibTeX
@article{Chan2023,
  author = {Chan, J S K and Lee, Y H A and Hui, J M H and Liu, K and Dee, E C and Ng, K and Tang, P and Tse, G and Ng, C F},
  title = {Long-term Cardiovascular Risks of Gonadotropin-releasing Hormone Agonists and Antagonists: A Population-based Cohort Study},
  journal = {Clinical Oncology},
  year = {2023},
  doi = {10.1016/j.clon.2023.03.014}
}
Kostenlos starten →